Specific PoC Testing of Coagulation in Patients Treated With DOAC 1 — SPOCT-DOAC 1  

Anticoagulation With NOAC Clinical Trial

Official title: Specific Point-of-Care Testing of Coagulation in Patients Treated With Direct Oral Anticoagulants Part 1

Status Recruiting

Clinical Trial Summary

The investigators study aims to test the correlation between the Cascade Abrazo point-of-care testing (POCT) device (Helena Laboratories, USA) and plasma levels of apixaban, dabigatran, edoxaban and rivaroxaban, and to determine the diagnostic accuracy of POCT to rule out or detect relevant levels of direct oral anticoagulants (DOAC) in real-life patients.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Anticoagulation With NOAC

• NCT number: NCT02825394
• Study type: Observational
• Source: University Hospital Tuebingen
• Contact: Sven Poli, MD MSc
• Phone: +497071290
• Email: sven.poli@uni-tuebingen.de
• Status: Recruiting
• Start date: October 13, 2016
• Completion date: July 2021